Related Experiment Video
Updated: Jun 22, 2026

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
Published on: February 10, 2021
Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration
Anna Machalińska1, Violetta Dziedziejko, Katarzyna Mozolewska-Piotrowska
1Department of Physiopathology, Pomeranian Medical University, Szczecin, Poland.
Insights
Elevated levels of C3a-desArg, a complement compound, are linked to exudative age-related macular degeneration (AMD) and atherosclerosis. This suggests AMD may be a systemic condition.
Area of Science:
- Ophthalmology
- Immunology
- Cardiovascular Medicine
Background:
- Chronic inflammation is implicated in age-related macular degeneration (AMD) progression.
- The role of specific complement system components in AMD pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the association between plasma C3a-desArg concentrations and the development of different forms of AMD.
- To explore the relationship between C3a-desArg levels, AMD, and comorbid conditions like atherosclerosis.
Main Methods:
- A case-control study involving 90 participants: 30 with exudative AMD, 30 with dry AMD, and 30 healthy controls.
- Measurement of plasma C3a-desArg concentrations using peripheral blood samples.
- Statistical analysis to evaluate associations between C3a-desArg levels and clinical factors including age, sex, smoking, atherosclerosis, and hypertension.
Main Results:
- Significantly elevated C3a-desArg levels were observed in patients with exudative AMD compared to controls.
- C3a-desArg concentrations in dry AMD patients were comparable to those in the control group.
- Individuals with atherosclerosis (AS) showed higher C3a-desArg levels, irrespective of AMD status.
Conclusions:
- Systemic complement activation, indicated by elevated C3a-desArg, is associated with the development of choroidal neovascularization (CNV) in AMD.
- Complement activation is linked to atherosclerosis, supporting the hypothesis that AMD can manifest as a local sign of a systemic disease.
Aim:
Recent findings suggest that chronic inflammatory processes play a role in the progression of age-related macular degeneration (AMD). Here we asked whether the development of different forms of AMD is connected with the elevation of plasma C3a-desArg concentration.
Methods:
We recruited 30 subjects with a clinical diagnosis of exudative AMD with newly diagnosed choroidal neovascularization (CNV), 30 subjects with dry AMD and 30 age- and sex-matched volunteers without AMD. The concentration of C3a-desArg complement compound was measured in the subjects' peripheral blood. We evaluated the association between the level of C3a-desArg and age, sex, smoking, atherosclerosis, and hypertension.
Results:
We found that the levels of C3a-desArg were significantly elevated in patients with exudative AMD compared to the control group. The concentrations of C3a-desArg in patients with dry AMD were similar to those of controls. Additionally, patients and controls with documented atherosclerosis (AS) displayed significantly higher levels of C3a-desArg compared to subjects without AS.
Conclusions:
Our results suggest an association between systemic complement activation and the development of CNV. Moreover, we found an association of complement activation with atherosclerosis and confirmed the hypothesis that AMD can be a local manifestation of systemic disease.
Related Concept Videos
Complement System
Glaucoma: Overview
Diabetic Retinopathy
Cerebral Edema ll: Pathophysiology

